Literature DB >> 35837196

Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway.

Zhuying Yang1, Liang Xia1.   

Abstract

Background: We aimed to study the effects and potential mechanism of resveratrol (RS) in gastric cancer (GC).
Methods: The human GC cell line SGC7901 was treated with different concentrations of RS (0, 1, 5 µM) for 24 hours. The messenger ribonucleic acid or protein expressions levels of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), micro ribonucleic acid-383-5p (miR-383-5p), and DNA damage-inducible transcript 4 (DDIT4) in GC cells were determined by Western blot and quantitative real-time polymerase chain assays. Cells were then transfected with miR-383-5p inhibitor (inhibitor), inhibitor negative control (NC), MALAT1-interfering RNA (si-MALAT1), si-DDIT4 and negative interference control (si-NC). The Cell Counting Kit-8 method, scratch assay, and transwell assay were performed to evaluate cell proliferation, migration, and invasion. Additionally, flow cytometry was used to examine apoptosis, and the target relationship was examined by a luciferase-reporter gene analysis.
Results: RS treatment downregulated the expression of MALAT1, repressed cell proliferation, inhibited cell migration and invasion (all P<0.05), and induced apoptosis (P<0.05) in GC cells. When the cells were treated with RS and inhibited the expression of MALAT1 meanwhile, the above anti-cancer effects were more significant (all P<0.05). Target prediction and the luciferase-reporter gene analysis showed that MALAT1 targeted miR-383-5p (P<0.05). When suppressing the expression of MALAT1 and miR-383-5p, the anti-cancer effects caused by the silencing of MALAT1 were absent (all P<0.05). We also found that miR-383-5p targeted DDIT4 protein. When the expression of miR-383-5p and DDIT4 in the GC cells was inhibited, the promoting cancer effects caused by the inhibition of miR-383-5p were reversed (all P<0.05). Conclusions: This study found that RS inhibited the proliferation, migration, and invasion of human GC cells through the metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)/miR-383-5p/DDIT4 pathway and induced apoptosis. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  MALAT1/miR-383-5p/DDIT4 pathway; Resveratrol; gastric cancer cell

Year:  2022        PMID: 35837196      PMCID: PMC9274040          DOI: 10.21037/jgo-22-307

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  31 in total

1.  Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition PIM-1 kinase activity.

Authors:  Sujin Kim; Wonki Kim; Do-Hee Kim; Jeong-Hoon Jang; Su-Jung Kim; Sin-Aye Park; Hyunggu Hahn; Byung Woo Han; Hye-Kyung Na; Kyung-Soo Chun; Bu Young Choi; Young-Joon Surh
Journal:  Arch Biochem Biophys       Date:  2020-05-27       Impact factor: 4.013

Review 2.  Resveratrol as an anti-cancer agent: A review.

Authors:  Abdur Rauf; Muhammad Imran; Masood Sadiq Butt; Muhammad Nadeem; Dennis G Peters; Mohammad S Mubarak
Journal:  Crit Rev Food Sci Nutr       Date:  2017-07-21       Impact factor: 11.176

3.  Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.

Authors:  Jun Wu; Junxian Yu; Jing Wang; Chenguang Zhang; Kun Shang; Xiaojun Yao; Bangwei Cao
Journal:  Biomed Pharmacother       Date:  2018-02-08       Impact factor: 6.529

4.  Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells.

Authors:  Thae Hyun Kim; Ji Hye Park; Jae Suk Woo
Journal:  Mol Med Rep       Date:  2019-02-15       Impact factor: 2.952

5.  Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses' Health Studies.

Authors:  Maryam S Farvid; Michelle D Holmes; Wendy Y Chen; Bernard A Rosner; Rulla M Tamimi; Walter C Willett; A Heather Eliassen
Journal:  Cancer Res       Date:  2020-11-15       Impact factor: 12.701

6.  Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.

Authors:  Yujun Wang; Ernest Han; Quanhua Xing; Jin Yan; Amanda Arrington; Charles Wang; Dylan Tully; Claudia M Kowolik; David M Lu; Paul H Frankel; Jing Zhai; Wei Wen; David Horne; M L Richard Yip; John H Yim
Journal:  Cancer Lett       Date:  2014-12-25       Impact factor: 8.679

Review 7.  Noncoding RNAs as Molecular Targets of Resveratrol Underlying Its Anticancer Effects.

Authors:  Man Wang; Shuai Jiang; Fei Yu; Li Zhou; Kun Wang
Journal:  J Agric Food Chem       Date:  2019-04-22       Impact factor: 5.279

8.  Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway.

Authors:  Senthil Selvaraj; Yuyang Sun; Pramod Sukumaran; Brij B Singh
Journal:  Mol Carcinog       Date:  2015-04-27       Impact factor: 4.784

9.  Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition.

Authors:  Zhuying Yang; Qigui Xie; Zhanlei Chen; Haibin Ni; Liang Xia; Qiufeng Zhao; Zhiyun Chen; Peifeng Chen
Journal:  Exp Ther Med       Date:  2018-12-28       Impact factor: 2.447

10.  High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer.

Authors:  Fahimeh Fattahi; Leili Saeednejad Zanjani; Zohreh Habibi Shams; Jafar Kiani; Mitra Mehrazma; Mohammad Najafi; Zahra Madjd
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.